Context Therapeutics announced it raised $100 Million in an initial filing from an offering of $100 Million

May 16, 2024•about 1 year ago

Amount Raised

$100 Million

PhiladelphiaHealthcare

Company Information

Company

Context Therapeutics

Location

2001 MARKET STREET

Philadelphia, Pennsylvania, United States

About

Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Context Therapeutics announced it raised $100 Million in an initial filing from an offering of $100 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information